Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The HIV envelope glycoproteins are central in the transmission of HIV-1, and are strongly implicated in the pathogenic effects of this virus. As we move through the second decade of HIV research, we are faced with the fact that we have yet to adequately describe the molecular events that determine the outcome of HIV infection. Despite having a detailed understanding of certain aspects of the virus-host interaction, a comprehensive overview is lacking. In the absence of such an overview, effective and long-lasting therapeutic treatment will be difficult to put into practice. In this review, the transmission and pathogenesis of HIV infection are discussed in the context of current developments according to our understanding of the structure and function of the HIV envelope glycoproteins. The potential for development or improvement of therapeutic strategies, based on targeting the envelope glycoproteins, is addressed.

Original publication




Journal article


Perspectives in Drug Discovery and Design

Publication Date





1 - 16